Post-approval studies (Phase 4)Not Yet RecruitingNCT07675252
What this trial is testing
Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Infants Aged 0-24 Months
Who this might be right for
Acute Wheezing Disorders in Infants Aged 0 to 24 Months
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 240